Summit Therapeutics
SMMT
#1661
Rank
S$16.12 B
Marketcap
S$20.80
Share price
3.88%
Change (1 day)
-13.30%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: S$16.12 Billion

As of March 2026 Summit Therapeutics has a market cap of S$16.12 Billion. This makes Summit Therapeutics the world's 1661th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026S$16.12 B-6.97%
2025S$17.33 B-5.02%
2024S$18.25 B655.58%
2023S$2.41 B110.61%
2022S$1.14 B222.79%
2021S$0.35 B-30.52%
2020S$0.51 B252.96%
2019S$0.14 B460.6%
2018S$25.84 M-88.31%
2017S$0.22 B45.19%
2016S$0.15 B-23.6%
2015S$0.19 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Summit Therapeutics was reported to be:

S$16.12 Billion
by Nasdaq info icon info icon
S$16.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
S$2.36 B-85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$0.28 B-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
S$0.37 B-97.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
S$7.85 B-51.31%๐Ÿ‡บ๐Ÿ‡ธ USA